Found 52 results
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is N  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
N
J. Nyombayire, Anzala, O., Gazzard, B., Karita, E., Bergin, P., Hayes, P., Kopycinski, J., Omosa-Manyonyi, G., Jackson, A., Bizimana, J., Farah, B., Sayeed, E., Parks, C. L., Inoue, M., Hironaka, T., Hara, H., Shu, T., Matano, T., Dally, L., Barin, B., Park, H., Gilmour, J., Lombardo, A., Excler, J. - L., Fast, P., Laufer, D. S., and Cox, J. H., First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens, J Infect Dis, vol. 215, no. 1, pp. 95-104, 2017.
J. Nyombayire, Anzala, O., Gazzard, B., Karita, E., Bergin, P., Hayes, P., Kopycinski, J. T., Omosa, G., Jackson, A., Bizimana, J., Farah, B., Sayeed, E., Parks, C., Inoue, M., Gilmour, J., Lombardo, A., Fast, P. E., Laufer, D., and Cox, J. H., Recombinant Sendai Vaccine Delivered Mucosally Induces Potent Gag-Specific T-Cell or Antibody Responses Depending on Prime Boost Regimen in Humans, in HIV R4P 2016, Chicago, IL, 2016.
R. B. Nussenblatt, Thompson, D. J. S., Li, Z., Peterson, J. S., Robinson, R. R., Shames, R. S., Nagarajan, S., Tang, M. T., Mailman, M., Velez, G., Roy, C., Levy-Clarke, G. A., Suhler, E. B., Djalilian, A., Sen, H. N., Al-Khatib, S., Ursea, R., Srivastava, S., Bamji, A., Mellow, S., Sran, P., and , Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration, J Autoimmun, vol. 21, pp. 283-293, 2003.
R. Nussenblatt, Li, Z., Robinson, R., Shames, R., Tang, M., Mailman, M., Thompson, D., Peterson, J., Sen, H., Al-Khatib, S., Ursea, R., Srivastava, S., Bamji, A., Sran, P., Waldmann, T., and Buggage, R., Daclizumab therapy in Uveitis patients: Preliminary safety and activity data for establishing parameters for subcutaneous administration for long term therapy, 2003.
R. B. Nussenblatt, Kim, J., Thompson, D. J. S., Davis, M. D., Chew, E., Ferris, F. L., and Buggage, R. R., Randomized Cinical Trial of Vitamin E in the Treatment of Uveitis-Associated Macular Edema, Am J Ophthalmol, vol. 141, pp. 193-194, 2006.
R. B. Nussenblatt, Rao, N. A., Foster, C. S., Sen, H. N., Srivastava, S., Ursea, R., Li, Z., Thompson, D. J., Peterson, J. S., Robinson, R. R., Shames, R. S., and Buggage, R. R., Subcutaneously administered daclizumab (SC-DAC, humanized anti-IL-2 receptor antibody) therapy for uveitis, 2003.
R. B. Nussenblatt, Fortin, E., Schiffman, R., Rizzo, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., and Whitcup, S. M., Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial, Proceedings of the National Academy of Science USA, vol. 96, pp. 7462-66, 1999.
R. B. Nussenblatt, Rao, N., Foster, C. S., Sen, H. N., Ursea, R., Li, Z., Thompson, D. J., Peterson, J. S., Shames, R. S., and Buggage, R. R., Uveitis therapy: a phase II study using subcutaneously administered daclizumab, 2004.
R. B. Nussenblatt, Fortin, E., Schiffman, R., Risso, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., and Whitcup, S. M., The use of monoclonal therapy in the treatment of intraocular inflammatory disease, 2000.
R. N. Nussenblatt, Buggage, R., Thompson, D., Zhuqing, L., Ragheb, J., and Waldmann, T., 4 Year Daclizumab Therapy for Sight Threatening Uveitis, in Annual Meeting of the Federation of Clinical Immunology Societies, San Francisco, CA, 2002.
R. B. Nussenblatt, Peterson, J. S., Foster, C. S., Rao, N. A., See, R. F., Letko, E., and Buggage, R. R., Initial Evaluation of Subcutaneous Daclizumab Treatments for Noninfectious Uveitis: A Multicenter Noncomparative Interventional Case Series, Ophthalmology, vol. 112, pp. 764-770, 2005.
A. Nowak-Węgrzyn, Wood, R. A., Nadeau, K. C., Pongracic, J. A., Henning, A. K., Lindblad, R. W., Beyer, K., and Sampson, H. A., Multicenter, randomized, double-blind, placebo-controlled clinical trial of vital wheat gluten oral immunotherapy., J Allergy Clin Immunol, 2018.
T. E. Novak, Neu, A., Martz, K., Fivush, B., Stablein, D., and Mathews, R. I., Progression to End-stage Renal Disease in Children with Vesicoureteral Reflux (VUR): Insights from an Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Database, in AAP, Boston, MA, 2008.
T. E. Novak, Mathews, iv, R., Martz, K., and Neu, A., Progression of Chronic Kidney Disease in Children with Vesicoureteral Reflux: The North American Pediatric Renal Trials and Collaborative Studies Database, J Urol, vol. 182, no. 4 Suppl, pp. 1678-1681, 2009.
K. D. Nolph, Lindblad, A. S., and Novak, J. W., Current Concepts. Continuous Ambulatory Peritoneal Dialysis, N Engl J Med, vol. 318, no. 24, pp. 1595-1600, 1988.
C. J. Nobles, Schisterman, E. F., Ha, S., Kim, K., Mumford, S. L., Louis, G. M. Buck, Chen, Z., Liu, D., Sherman, S., and Mendola, P., Ambient Air Pollution and Semen Quality, Environ Res, vol. 163, p. 228, 2018.
C. J. Nobles, Schisterman, E. F., Ha, S., Louis, G. M. Buck, Sherman, S., and Mendola, P., Time-Varying Cycle Average and Daily Variation in Ambient Air Pollution and Fecundability, Hum Reprod, vol. 33, no. 1, p. 166, 2018.
C. J. Nobles, Grantz, K. L., Liu, D., Williams, A., Ouidir, M., Seeni, I., Sherman, S., and Mendola, P., Ambient air pollution and fetal growth restriction: Physician diagnosis of fetal growth restriction versus population-based small-for-gestational age., Sci Total Environ, vol. 650, no. Pt.2, pp. 2641-2647, 2019.
C. J. Nobles, Grantz, K. L., Liu, D., Williams, A., Ouidir, M., Seeni, I., Sherman, S., and Mendola, P., Ambient air pollution and fetal growth restriction: Physician diagnosis of fetal growth restriction versus population-based small-for-gestational age., Sci Total Environ, vol. 650, no. Pt.2, p. 2641, 2018.
D. L. Noah, Hill, H., Hines, D., White, E. L., and Wolff, M. C., Qualification of the Hemagglutination Inhibition Assay in Support of Pandemic Influenza Vaccine Licensure, Clin Vaccine Immunol, vol. 16, pp. 558-566, 2009.
N. N. Nissen, Barin, B., and Stock, P. G., Malignancy in the HIV-Infected Patients Undergoing Liver and Kidney Transplantation, Curr Opin Oncol, vol. 24, pp. 517-521, 2012.
M. Niskopoulou, Balaskas, K., Leung, I., Sallo, F. B., Clemons, T. E., Bird, A. C., and Peto, T., Is Indocyanine Green Angiography Useful for the Diagnosis of Macular Telangiectasia Type 2?, Br J Ophthalmol, vol. 97, pp. 946-948, 2013.
D. L. Nigam, Zhou, M., Cunningham, D., Chew, E., and Agron, E., Characterization of Reticular Drusen and Association with Age Macular Degeneration through Multiple Imaging Modalities, in Association for Research in Vision and Ophthalmology - ARVO, Ft. Lauderdale, FL, 2012.
B. P. Nicholson, Nigam, D., Toy, B., Stetson, P. F., Agron, E., Jacobs-El, N., Cunningham, D., Cukras, C., Wong, W., Wiley, H., Chew, E., Ferris, F., and Meyerle, C. B., Effect of Ranibizumab on High-Speed Indocyanine Green Angiography and Minimum Intensity Projection Optical Coherence Tomography Findings in Neovascular Age-Related Macular Degeneration, Retina, vol. 35, pp. 58-68, 2015.
R. C. Nichols and Fullmer, K. R., Ongoing, Prospective Multicenter Safety Study of Subcutaneous Amifostine for Non-Small Cell Lung Cancer (NSCLC), in Advancing Science of Clinical Oncology Annual Meeting, Orlando, FL, 2005.